Skip to main content

Table 5 Adverse events that could be related to the treatment

From: A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

Adverse event

Number of episodes

Categories of the adverse events

Number of patients affected

Vaginal bleeding

23

Reproduction

13

Depression

2

Psychiatric disorders

2

Loss of libido

2

Psychiatric disorders

2

Mood swings

1

Psychiatric disorders

1

Hot flush

10

Vascular

9

Night sweats

2

Skin disorders

2

Pain at injection site

2

General Disorders

1